Chemical probes of Escherichia coli uncovered through chemical-chemical interaction profiling with compounds of known biological activity.
While cell-based screens have considerable power in identifying new chemical probes of biological systems and leads for new drugs, a major challenge to the utility of such compounds is in connecting phenotype with a cellular target. Here, we present a systematic study to elucidate the mechanism of action of uncharacterized inhibitors of the growth of Escherichia coli through careful analyses of interactions with compounds of known biological activity. We studied growth inhibition with a collection of 200 antibacterial compounds when systematically combined with a panel of 14 known antibiotics of diverse mechanism and chemical class. Our work revealed a high frequency of synergistic chemical-chemical interactions where the interaction profiles were unique to the various compound pairs. Thus, the work revealed that chemical-chemical interaction data provides a fingerprint of biological activity and testable hypotheses regarding the mechanism of action of the novel bioactive molecules. In the study reported here, we determined the mode of action of an inhibitor of folate biosynthesis and a DNA gyrase inhibitor. Moreover, we identified eight membrane-active compounds, found to be promiscuously synergistic with known bioactives.
Farha
Maya A
MA
Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8N 3Z5, Canada.
Brown
Eric D
ED
D000890:Anti-Infective Agents / Q000737:chemistry* / Q000494:pharmacology*; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D016000:Cluster Analysis; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D004357:Drug Synergism; D004926:Escherichia coli / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D005492:Folic Acid / Q000096:biosynthesis; D009643:Norfloxacin / Q000494:pharmacology; D013420:Sulfamethoxazole / Q000494:pharmacology; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism; D059005:Topoisomerase II Inhibitors
D000890:Anti-Infective Agents; D059005:Topoisomerase II Inhibitors; D005492:Folic Acid; D013762:Tetrahydrofolate Dehydrogenase; D013420:Sulfamethoxazole; D009643:Norfloxacin